Evidence map›Paper›PMID 42248820›Full record

ArticleNature communications2026

Structural basis for a filamentous morpheein model of human cystathionine beta-synthase.

Inayathulla Mohammed, Ela Mijatovic, Thilo Magnus Philipp, Lucia Janickova, Kelly Ascencao, Francisco J Asturias, Luis Alfonso Martinez-Cruz, Csaba Szabo, Henning Stahlberg, Tomas Majtan

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Inayathulla MohammedLaboratory of Biological Electron Microscopy, Institute of Physics, School of Basic Sciences, Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland. inayathulla.mohammed@epfl.ch.
Ela MijatovicSection of Pharmacology, Department of Oncology, Microbiology and Immunology, University of Fribourg, Fribourg, Switzerland.
Thilo Magnus PhilippSection of Pharmacology, Department of Oncology, Microbiology and Immunology, University of Fribourg, Fribourg, Switzerland.ORCID http://orcid.org/0000-0002-4730-4218
Lucia JanickovaSection of Pharmacology, Department of Oncology, Microbiology and Immunology, University of Fribourg, Fribourg, Switzerland.
Kelly AscencaoSection of Pharmacology, Department of Oncology, Microbiology and Immunology, University of Fribourg, Fribourg, Switzerland.ORCID http://orcid.org/0000-0001-6693-6897
Francisco J AsturiasDepartment of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Luis Alfonso Martinez-CruzCenter for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain.ORCID http://orcid.org/0000-0002-5856-9377
Csaba SzaboSection of Pharmacology, Department of Oncology, Microbiology and Immunology, University of Fribourg, Fribourg, Switzerland.ORCID http://orcid.org/0000-0003-3110-4235
Henning StahlbergLaboratory of Biological Electron Microscopy, Institute of Physics, School of Basic Sciences, Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland.ORCID http://orcid.org/0000-0002-1185-4592
Tomas MajtanSection of Pharmacology, Department of Oncology, Microbiology and Immunology, University of Fribourg, Fribourg, Switzerland. tomas.majtan@unifr.ch.ORCID http://orcid.org/0000-0002-2751-2124

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 10.001.133Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) CRSII5_177195Université de Fribourg (Universität Freiburg) 22-15
6 · The paper itself

Abstract

Human cystathionine beta-synthase (CBS) is a vital enzyme that regulates sulfur amino acid metabolism, hydrogen sulfide production, and cellular redox balance. Using a multidisciplinary approach, we demonstrate that CBS functions as a filamentous morpheein, with its stability, turnover, and activity governed by dynamic quaternary structural transitions. Three distinct filamentous assemblies were resolved by cryo-EM and are mediated by the oligomerization loop (residues 516-525): (i) ligand-free trans-dimers that form trans-basal filaments with basal stability and activity, (ii) adenosylornithine-bound cis-dimers that assemble into stabilized cis-basal filaments and (iii) S-adenosylmethionine-bound allo-dimers, which, together with cis-dimers, form highly stable, allo-activated stacked filaments. These reversible filamentous assemblies redefine CBS biology by integrating oligomerization and allosteric regulation within a morpheein framework. These findings provide a transformative perspective on CBS function and open avenues for pharmacological targeting of dysregulated CBS in various diseases including homocystinuria, cancer, and Down syndrome.

Indexed as

Cystathionine beta-SynthaseAllosteric RegulationCryoelectron MicroscopyHumansModels, MolecularProtein MultimerizationS-AdenosylmethionineCystathionine beta-SynthaseS-Adenosylmethionine

Identifiers

PMID42248820
PMCPMC13396399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.